Class Action Deadlines: Y-mAbs Therapeutics, Bioventus Inc, Fate Therapeutics, Inc, and Invivyd Inc – Contact Johnson Fistel
07 févr. 2023 10h57 HE
|
Johnson Fistel, LLP
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that class action lawsuits have commenced on behalf of investors of Y-mAbs Therapeutics, Inc....
Bioventus Inc. Shareholder News: Johnson Fistel Encourages BVS Shareholders with Losses to Contact the Firm Regarding Class Action Investigation
21 nov. 2022 08h48 HE
|
Johnson Fistel, LLP
SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ:...